Caricamento...
tPA-A(296-299) Prevents Impairment of Cerebral Autoregulation After Stroke Through LRP Dependent Increase in cAMP and p38
BACKGROUND AND PURPOSE: The sole FDA approved treatment for stroke is tPA, but its brief therapeutic window and complications of treatment constrain its use. One limitation may be its potential to exacerbate impairment of cerebral autoregulation after stroke. Vasodilation is maintained by elevations...
Salvato in:
| Pubblicato in: | Stroke |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4961526/ https://ncbi.nlm.nih.gov/pubmed/27354223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.012678 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|